For the year ending 2025-12-31, RRX had $128,200K increase in cash & cash equivalents over the period. $893,100K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 280,800 |
| Depreciation | 154,500 |
| Amortization | 346,100 |
| Goodwill impairment | 0 |
| Asset impairments | 0 |
| Noncash lease expense | 43,300 |
| Share-based compensation expense | 37,300 |
| Financing fee expense | 14,000 |
| Loss on sale of businesses | -4,500 |
| Gain on sale of assets | 2,600 |
| Benefit from deferred income taxes | -97,200 |
| Other non-cash changes | -5,600 |
| Receivables | -345,000 |
| Inventories | 62,700 |
| Accounts payable | 45,100 |
| Other assets and liabilities | 122,900 |
| Net cash provided by operating activities | 990,800 |
| Additions to property, plant and equipment | 97,700 |
| Business acquisitions, net of cash acquired | 0 |
| Proceeds received from sales of property, plant and equipment | 23,700 |
| Proceeds received from sale of businesses, net of cash transferred | 3,000 |
| Net cash (used in) provided by investing activities | -71,000 |
| Borrowings under revolving credit facility | 1,514,500 |
| Repayments under revolving credit facility | 1,554,500 |
| Proceeds from long-term borrowings | 0 |
| Repayments of long-term borrowings | 669,400 |
| Proceeds from short-term borrowings | 0 |
| Repayments of short-term borrowings | 0 |
| Dividends paid to shareholders | 93,000 |
| Shares surrendered for taxes | 8,400 |
| Proceeds from the exercise of stock options | 2,000 |
| Financing fees paid | 5,300 |
| Repurchase of common stock | 0 |
| Distributions to noncontrolling interests | 0 |
| Net cash (used in) provided by financing activities | -814,100 |
| Effect of exchange rates on cash and cash equivalents | 22,500 |
| Net increase (decrease) in cash and cash equivalents | 128,200 |
| Cash and cash equivalents at beginning of period | 393,500 |
| Cash and cash equivalents at end of period | 521,700 |
REGAL REXNORD CORP (RRX)
REGAL REXNORD CORP (RRX)